TRUBRIDGE INC (TBRG)
US2053061030 - Common Stock
Taking everything into account, TBRG scores 3 out of 10 in our fundamental rating. TBRG was compared to 37 industry peers in the Health Care Technology industry. TBRG has a bad profitability rating. Also its financial health evaluation is rather negative. TBRG is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
TBRG had positive earnings in the past year.
TBRG had a positive operating cash flow in the past year.
TBRG had positive earnings in 4 of the past 5 years.
Each year in the past 5 years TBRG had a positive operating cash flow.
1.2 Ratios
TBRG's Return On Assets of -15.12% is fine compared to the rest of the industry. TBRG outperforms 62.86% of its industry peers.
Looking at the Return On Equity, with a value of -35.16%, TBRG is in line with its industry, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.12% | ||
| ROE | -35.16% | ||
| ROIC | N/A |
ROA(3y)-0.66%
ROA(5y)1.61%
ROE(3y)-3.06%
ROE(5y)1.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TBRG has a Gross Margin (49.41%) which is in line with its industry peers.
In the last couple of years the Gross Margin of TBRG has declined.
The Profit Margin and Operating Margin are not available for TBRG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-2.03%
2. Health
2.1 Basic Checks
TBRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TBRG has more shares outstanding
TBRG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TBRG has a worse debt to assets ratio.
2.2 Solvency
TBRG has an Altman-Z score of 1.88. This is not the best score and indicates that TBRG is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of TBRG (1.88) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.00 is on the high side and indicates that TBRG has dependencies on debt financing.
With a Debt to Equity ratio value of 1.00, TBRG is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.88 |
ROIC/WACCN/A
WACC9.38%
2.3 Liquidity
A Current Ratio of 1.80 indicates that TBRG should not have too much problems paying its short term obligations.
TBRG has a Current ratio of 1.80. This is comparable to the rest of the industry: TBRG outperforms 57.14% of its industry peers.
TBRG has a Quick Ratio of 1.78. This is a normal value and indicates that TBRG is financially healthy and should not expect problems in meeting its short term obligations.
TBRG has a Quick ratio (1.78) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.78 |
3. Growth
3.1 Past
The earnings per share for TBRG have decreased strongly by -75.49% in the last year.
Measured over the past years, TBRG shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.46% on average per year.
Looking at the last year, TBRG shows a very strong growth in Revenue. The Revenue has grown by 24.98%.
The Revenue has been growing slightly by 3.90% on average over the past years.
EPS 1Y (TTM)-75.49%
EPS 3Y-6.92%
EPS 5Y-6.46%
EPS Q2Q%-146.67%
Revenue 1Y (TTM)24.98%
Revenue growth 3Y8.67%
Revenue growth 5Y3.9%
Sales Q2Q%1.35%
3.2 Future
Based on estimates for the next years, TBRG will show a small growth in Earnings Per Share. The EPS will grow by 5.32% on average per year.
TBRG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.62% yearly.
EPS Next Y-71.32%
EPS Next 2Y-4.66%
EPS Next 3Y5.32%
EPS Next 5YN/A
Revenue Next Year-0.66%
Revenue Next 2Y2.64%
Revenue Next 3Y4.62%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 41.32, which means the current valuation is very expensive for TBRG.
TBRG's Price/Earnings ratio is a bit cheaper when compared to the industry. TBRG is cheaper than 80.00% of the companies in the same industry.
TBRG is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
TBRG is valuated correctly with a Price/Forward Earnings ratio of 12.70.
94.29% of the companies in the same industry are more expensive than TBRG, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.69. TBRG is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.32 | ||
| Fwd PE | 12.7 |
4.2 Price Multiples
74.29% of the companies in the same industry are more expensive than TBRG, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.4 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.66%
EPS Next 3Y5.32%
5. Dividend
5.1 Amount
No dividends for TBRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TRUBRIDGE INC
NASDAQ:TBRG (1/3/2025, 8:05:04 PM)
After market: 21 +0.34 (+1.65%)20.66
+0.76 (+3.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners80.77%
Inst Owner Change0%
Ins Owners2.29%
Ins Owner Change0.49%
Market Cap308.45M
Analysts78.18
Price Target18.77 (-9.15%)
Short Float %2.27%
Short Ratio4.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.99%
Min EPS beat(2)-176.25%
Max EPS beat(2)-7.73%
EPS beat(4)2
Avg EPS beat(4)-39.74%
Min EPS beat(4)-176.25%
Max EPS beat(4)24.18%
EPS beat(8)4
Avg EPS beat(8)-25.4%
EPS beat(12)6
Avg EPS beat(12)-15.77%
EPS beat(16)8
Avg EPS beat(16)-10.97%
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)0.92%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-1.68%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-1.49%
Revenue beat(12)4
Avg Revenue beat(12)-0.32%
Revenue beat(16)5
Avg Revenue beat(16)-0.86%
PT rev (1m)22.67%
PT rev (3m)50.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-29.06%
EPS NY rev (1m)-6.79%
EPS NY rev (3m)-38.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.99%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.32 | ||
| Fwd PE | 12.7 | ||
| P/S | 0.73 | ||
| P/FCF | N/A | ||
| P/OCF | 32.34 | ||
| P/B | 1.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.4 |
EPS(TTM)0.5
EY2.42%
EPS(NY)1.63
Fwd EY7.87%
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.64
OCFY3.09%
SpS28.19
BVpS11.56
TBVpS-8.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.12% | ||
| ROE | -35.16% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.41% | ||
| FCFM | N/A |
ROA(3y)-0.66%
ROA(5y)1.61%
ROE(3y)-3.06%
ROE(5y)1.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-2.03%
F-Score6
Asset Turnover1.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.79 | ||
| Cap/Depr | 67.32% | ||
| Cap/Sales | 4.76% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 42.87% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.78 | ||
| Altman-Z | 1.88 |
F-Score6
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)77.47%
Cap/Depr(5y)59.31%
Cap/Sales(3y)5.5%
Cap/Sales(5y)3.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.49%
EPS 3Y-6.92%
EPS 5Y-6.46%
EPS Q2Q%-146.67%
EPS Next Y-71.32%
EPS Next 2Y-4.66%
EPS Next 3Y5.32%
EPS Next 5YN/A
Revenue 1Y (TTM)24.98%
Revenue growth 3Y8.67%
Revenue growth 5Y3.9%
Sales Q2Q%1.35%
Revenue Next Year-0.66%
Revenue Next 2Y2.64%
Revenue Next 3Y4.62%
Revenue Next 5YN/A
EBIT growth 1Y-466.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.84%
EBIT Next 3Y21.5%
EBIT Next 5YN/A
FCF growth 1Y-140.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.07%
OCF growth 3Y-72.17%
OCF growth 5Y-46.4%